FDA Approves Inluriyo and Verzenio Combination for Certain Advanced Breast Cancers
The FDA approves Inluriyo with Verzenio for certain ESR1-mutated advanced breast cancers…
WHO Calls for More Research to Assess Traditional Medicine
WHO launches a 2025–2034 research agenda to strengthen evidence on traditional medicine,…
AI Analysis of Pathology Slides May Help Predict Pancreatic Cancer Recurrence
AI-enabled analysis of routine pathology slides may help identify pancreatic cancer patients…
Pancreatic Cyst Study Estimates Cancer Risk to Support Early Detection
Mayo Clinic researchers estimate three-year cancer risk in patients with pancreatic cysts,…
Personalized mRNA Therapy Shows Positive Phase 3 Results in Melanoma
Merck and Moderna report positive Phase 3 results for their personalized mRNA…
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development…
FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer
The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…
New Phase III Data Shows Survival Benefit in Advanced Gastric Cancer
AstraZeneca reports positive Phase III CLARITY-Gastric01 results showing sonesitatug vedotin significantly improves…
New Research Collaboration Aims to Advance Personalized Cancer Treatment
GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration to…
WHO Warns Global Cancer Cases Could Nearly Double by 2050
WHO has warned that global cancer cases could nearly double by 2050,…
